Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Cilofexor

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 286,399Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Boehringer Ingelheim and Yuhan Corp. in US$870m NASH deal
    Boehringer Ingelheim and Yuhan Corp. in US$870m NASH deal

    02 Jul 2019

    // EUROPEAN BIOTECHNOLOGY

    https://european-biotechnology.com/up-to-date/latest-news/news/boehringer-ingelheim-and-yuhan-corp-in-us870m-nash-deal.html

    EUROPEAN BIOTECHNOLOGY
    02 Jul 2019
    Share Share
    Gilead teams up with Insitro for experimental NASH treatments
    Gilead teams up with Insitro for experimental NASH treatments

    17 Apr 2019

    // Saumya S. Joseph REUTERS

    https://www.reuters.com/article/us-gilead-sciences-insitro-nash/gilead-teams-up-with-insitro-for-experimental-nash-treatments-idUSKCN1RS11J?feedType=RSS&feedName=healthNews

    Saumya S. Joseph REUTERS
    17 Apr 2019
    Share Share
    Gilead announces Novo Nordisk NASH partnership after new data revealed
    Gilead announces Novo Nordisk NASH partnership after new data revealed

    15 Apr 2019

    // Anna Smith PHARMA TIMES

    http://www.pharmatimes.com/news/gilead_announces_novo_nordisk_nash_partnership_after_new_data_revealed_1284382

    Anna Smith PHARMA TIMES
    15 Apr 2019
    Share Share
    Novo Nordisk and Gilead team up to test fatty liver disease treatment
    Novo Nordisk and Gilead team up to test fatty liver disease treatment

    13 Apr 2019

    // Stine Jacobsen REUTERS

    https://www.reuters.com/article/us-novo-nordisk-gilead-sciences-nash/novo-nordisk-and-gilead-team-up-to-test-fatty-liver-disease-treatment-idUSKCN1RO0Y3?feedType=RSS&feedName=healthNews

    Stine Jacobsen REUTERS
    13 Apr 2019
    Share Share
    Gilead posts combo NASH data from biotech buyouts
    Gilead posts combo NASH data from biotech buyouts

    11 Apr 2019

    // Ben Adams FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/gilead-posts-combo-nash-data-from-biotech-buyouts

    Ben Adams FIERCE BIOTECH
    11 Apr 2019
    Share Share